Corrigendum: Incidence of Guillain-Barré syndrome in South Korea during the early COVID-19 pandemic

Choi, Sun Ah; Hwang, Junho; Lim, Byung Chan; Chae, Soo Ahn

doi:10.3389/fneur.2023.1184177

CORRECTION article

Front. Neurol. , 11 April 2023

Sec. Neuroepidemiology

Volume 14 - 2023 | https://doi.org/10.3389/fneur.2023.1184177

Corrigendum: Incidence of Guillain-Barré syndrome in South Korea during the early COVID-19 pandemic

This article is a correction to:

Incidence of Guillain–Barré syndrome in South Korea during the early COVID-19 pandemic
1. Read original article

$\nSun Ah Choi$ Sun Ah Choi¹

Junho Hwang²

Byung Chan Lim³

Soo Ahn Chae²^*

¹Department of Pediatrics, Ewha Womans University Mokdong Hospital, Ewha Womans University College of Medicine, Seoul, Republic of Korea
²Department of Pediatrics, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Republic of Korea
³Department of Pediatrics, Seoul National University Children's Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea

A corrigendum on
Incidence of Guillain-Barré syndrome in South Korea during the early COVID-19 pandemic

by Choi, S. A., Hwang, J., Lim, B. C., and Chae, S. A. (2023). Front. Neurol. 14:1125455. doi: 10.3389/fneur.2023.1125455

In the published article, there was an error in Figure 3 as published. Subheadings for each graph were missing. The corrected Figure 3 and its caption appear below.

FIGURE 3

Figure 3. Time-series analysis of the nationwide infections from a nationwide infectious surveillance system. Dotted lines present the trends of infectious diseases using locally weighted scatterplot smoothing. ILI, Influenza-like illness.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: Guillain-Barré syndrome, SARS-CoV-2, COVID-19, nationwide infection, Campylobacter

Citation: Choi SA, Hwang J, Lim BC and Chae SA (2023) Corrigendum: Incidence of Guillain-Barré syndrome in South Korea during the early COVID-19 pandemic. Front. Neurol. 14:1184177. doi: 10.3389/fneur.2023.1184177

Received: 11 March 2023; Accepted: 28 March 2023;
Published: 11 April 2023.

Edited and reviewed by: Paolo Aridon, University of Palermo, Italy

Copyright © 2023 Choi, Hwang, Lim and Chae. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Soo Ahn Chae, a2lkYnJhaW5AY2F1LmFjLmty

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Corrigendum: Incidence of Guillain-Barré syndrome in South Korea during the early COVID-19 pandemic

Publisher's note

94% of researchers rate our articles as excellent or good

94% of researchers rate our articles as excellent or good